Subscribe
News
Latest News
Post a Press Release
View Press Releases
Submit a Story
Reprint Articles
Advertise
Media Kit
Digital Advertising Opportunities
Lead Generation
Whitepapers
Webinars
Podcasts
Editorial Calendar
Free Downloads
Whitepapers
Podcasts
Webinars
Inside Ebooks
Events
Webinars
Industry Events
Dx Conferences
Tri-Conference
Next Generation Dx
Dx Innovation Summit
About
Editorial Profile
Editorial Calendar
Contact
Next Generation Dx Summit
Latest News
Exosome Dx Aiming to Commercialize Liquid Biopsies Seeks 25M
January 28, 2015 |
Cambridge, MA-based Exosome Diagnostics aims to raise $25 million, on top of the $27 million in Series B funding it raised last March. Exosome would use the cash to launch its first two products: a blood-based test for lung cancer, and a urine test for prostate cancer.
Xconomy